Iel-Yong Sung

Iel-Yong Sung


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SJSoomi Jang
Soomi Jang
YKYoung-Hoon Kang
Young-Hoon Kang
IUImran Ullah
Imran Ullah
SSSharath Belame Shivakumar
Sharath Belame Shivakumar
GRGyu-Jin Rho
Gyu-Jin Rho
BPBong-Wook Park
Bong-Wook Park
The reduction of choline acetyltransferase, caused by the loss of cholinergic neurons, leads to the absence of acetylcholine (Ach), which is related to motor nerve degeneration. The aims of the present study were to evaluate the in vitro cholinergic nerve differentiation potential of mesenchymal stem cells from cryopreserved human dental pulp (hDPSCs-cryo) and to analyze the scale of in vivo motor nerve regeneration. The hDPSCs-cryo were isolated and cultured from cryopreserved dental pulp tissues, and thereafter differentiated into cholinergic neurons using tricyclodecane-9-yl-xanthogenate (D609). Differentiated cholinergic neurons (DF-chN) were transplanted into rats to address sciatic nerve defects, and the scale of in vivo motor nerve regeneration was analyzed. During in vitro differentiation, the cells showed neuron-like morphological changes including axonal fibers and neuron body development, and revealed high expression of cholinergic neuron-specific markers at both the messenger RNA (mRNA) and protein levels. Importantly, DF-chN showed significant Ach secretion ability. At eight weeks after DF-chN transplantation in rats with sciatic nerve defects, notably increased behavioral activities were detected with an open-field test, with enhanced low-affinity nerve growth factor receptor (p75NGFR) expression detected using immunohistochemistry. These results demonstrate that stem cells from cryopreserved dental pulp can successfully differentiate into cholinergic neurons in vitro and enhance motor nerve regeneration when transplanted in vivo. Additionally, this study suggests that long-term preservation of dental pulp tissue is worthwhile for use as an autologous cell resource in the field of nerve regeneration, including cholinergic nerves.

22 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JHJinhee Ha
Jinhee Ha
DBDinesh Bharti
Dinesh Bharti
YKYOUNGHOON KANG
YOUNGHOON KANG
SLSang-Yeob Lee
Sang-Yeob Lee
SOSeong-Ju Oh
Seong-Ju Oh
JPJeong-Kil Park
Jeong-Kil Park
Previous studies have shown that mesenchymal stem cells (MSCs) derived from various tissue sources can be differentiated into smooth muscle‐like cells (SMLCs) in vitro. In this paper, dental pulp‐derived mesenchymal stem cells (DPSCs) were evaluated for their differentiation ability towards smooth muscle‐like cells (SMLCs) under the effect of widely used cytokines (TGF‐β1 and PDGF‐BB) with special focus on different culturing environments. For this purpose, both the commercially used culturing plates (Norm‐c) and 0.1% gelatin‐precoated (Gel‐c) plates were used. Isolated cells displayed plastic adherence, pluripotency and cell surface marker profiling, and adipogenic and osteogenic differentiation potential with lineage specific marker expression. Differentiated cells induced under different culturing plates showed successful differentiation into SMLCs by positively expressing smooth muscle cell (SMC) specific markers both at the mRNA and protein levels. Gelatin coating could substantially enhance DPSC differentiation potential than Norm‐c‐induced cells. However, the absence of mature marker MHY‐11 by immunostaining results from all treatment groups further indicated the development of immature and synthetic SMLCs. Finally, it was concluded that DPSC differentiation ability into SMLCs can be enhanced under cytokine treatment as well as by altering the cellular niche by precoating the culturing plates with suitable substrates. However, to get fully functional, contractile, and mature SMLCs, still many different cytokine cocktail combinations and more suitable coating substrates will be needed.

1 January 2015 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
ISIel-Yong Sung
Iel-Yong Sung
YKYoung-Min Kim
Young-Min Kim
YCYeong-Cheol Cho
Yeong-Cheol Cho
JSJang-Ho Son
Jang-Ho Son
Sung IY, et al. J Periodontal Implant Sci. 2015 Dec;45(6):247-251. http://dx.doi.org/10.5051/jpis.2015.45.6.247

31 December 2022 in Journal of the Korean Association of Oral and Maxillofacial Surgeons
Verified
Journal Article
Open access
PDF file
HKHoon-Min Kim
Hoon-Min Kim
SLSe-Jeong Lim
Se-Jeong Lim
YCYeong-Cheol Cho
Yeong-Cheol Cho
ISIel-Yong Sung
Iel-Yong Sung
JSJang-Ho Son
Jang-Ho Son
Hoon-Min Kim, Se-Jeong Lim, Yeong-Cheol Cho, Iel-Yong Sung, Jang-Ho Son. JKAOMS 2022;48:386-9. https://doi.org/10.5125/jkaoms.2022.48.6.386

16 September 2024 in Medicina
Verified
Journal Article
Open access
PDF file
HKHYO-JUNG KIM
HYO-JUNG KIM
ISIel-Yong Sung
Iel-Yong Sung
Background and Objectives: With increases in cancer incidence and the number of cancer survivors, the demand for cancer management is growing. However, studies on dental prosthetic treatment for patients with cancer are rare. We aim to investigate the dental prosthetic treatment in patients with cancer aged ≥65 years after expanded health insurance coverage. Materials and Methods: This retrospective study included patients who were treated with implants and removable dentures at Ulsan University Hospital in South Korea between June 2015 and June 2023. Data on age, sex, cancer location, comorbid systemic diseases, number of remaining teeth, dental prosthetic treatment history, type of dental prosthetic treatment, and insurance coverage status were extracted from patient medical records and panoramic radiographs. The influence of multiple variables on dental prosthetic treatment was analyzed using the Chi-square and Fisher’s exact tests. Results: The study included 61 patients with cancer (32 men, 29 women; average age: 70.9 years). Among them, 56 (91.8%) had insurance coverage benefits, and 34 (55.7%) received treatments such as implants, removable partial dentures, or complete dentures for the first time. Treatment types included 37 (60.7%) cases of implant prostheses and 24 (39.3%) conventional removable dentures. No statistical differences were observed in the type of dental prosthetic treatment according to sex, age, cancer location, number of systemic diseases, and dental prosthetic treatment history (p > 0.05). Patients with <10 remaining teeth received treatment with conventional removable dentures, which was statistically significant (p < 0.001). Conclusions: Of the 61 patients, 56 (91.8%) received insurance benefits, and 34 (55.7%) underwent dental prosthetic treatment for the first time. Within the limitations of this retrospective study, the expanded health insurance coverage alleviated the unmet demand for dental prosthetic treatment. As cancer prevalence continues to increase, expanding customized health insurance coverage is crucial to meet this demand.

1 January 2011 in Journal of the Korean Association of Oral and Maxillofacial Surgeons
Verified
Journal Article
Open access
PDF file
YCYeong-Cheol Cho
Yeong-Cheol Cho
SJSoo-Mi Jang
Soo-Mi Jang
SPSoo-Won Park
Soo-Won Park
BCByung-Hwan Choi
Byung-Hwan Choi
JHJin-Hee Ha
Jin-Hee Ha
ISIel-Yong Sung
Iel-Yong Sung
Cho YC, et al. J Korean Assoc Oral Maxillofac Surg. 2011 Jun;37(3):234-236. http://dx.doi.org/10.5125/jkaoms.2011.37.3.234